Dow Up 0.07% Nasdaq Up 0.61%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
2.16 Up 0.28(15.20%) 4:00PM EST
Prev Close:1.88
Open:1.86
Bid:N/A
Ask:3.46 x 100
1y Target Est:10.17
Beta:2.01
Next Earnings Date:N/A
Day's Range:1.86 - 2.18
52wk Range:1.64 - 6.84
Volume:459,068
Avg Vol (3m):493,165
Market Cap:45.65M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXIIUp 15.20%45.65M
AGNUp 0.90%63.75B
ALNYUp 3.62%7.75B
MRNAUp 5.94%27.50M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):460.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.90
Quarterly EPS Est (Dec-14) :-0.19
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback